Announcement of an Exempt Purchase

Ingenuity Pathway Analysis (IPA) software license supports the analytical activity of a wide range of biomedical researchers in interpreting and generating hypotheses from biomedical data sets.

This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for performing sponsored research and other sponsored activities under grants and contracts funded by the sponsor or by sources other than State appropriations. (30 ILCS 500 / 1-13(b)(8)) This software license supports the analytical activity of a wide range of biomedical researchers in interpreting and generating hypotheses from biomedical data sets. It is a key component of a number of grant applications and awarded grants from the National Institute of Health (NIH). There are currently 53 active users across different colleges and departments that rely on access for their research. Without access to IPA these researchers and their projects will be negatively impacted.